
1. int j cancer. 2009 sep 1;125(5):1161-7. doi: 10.1002/ijc.24444.

high prevalence human papillomavirus infection female population of
guatemala.

vallès x(1), murga gb, hernández g, sabidó m, chuy a, lloveras b, alameda f, de
san josé s, bosch fx, pedroza i, castellsagué x, casabona j.

author information: 
(1)institut català d'oncologia, idibell, l'hospitalet de llobregat, barcelona,
spain. xavier_valles04@hotmail.com

the potential introduction newly licensed hpv-vaccines affordable
prices could play central role preventing cervical cancer middle and
low-income countries, cases occur. spite this, basic
epidemiological data hpv hpv-related lesions still scarce. to
determine prevalence cervical abnormalities, hpv prevalence, genotype
distribution related risk factors, carried cross-sectional study 
a population guatemala included 297 women general population
(gp women) 297 sex workers (sw). participating women interviewed and
underwent complete gynecological examination included collection of
cervical cells cytological diagnosis, hpv dna detection typing pcr
methods. cervical hpv dna prevalence among gp women sw 38.1% (95%
ci: 32.5-43.8) 67.3% (95% ci: 61.7-72.6), respectively. prevalence of
abnormal cytology among gp women 7.7% (ascus = 1.4%, lsil = 4.7%, asc-h =
0.3% hsil = 1.4%) among sw 21.6% (ascus = 7.5%, lsil = 10.6%, asc-h =
1.4% hsil = 2.1%). prevalent hpv types among women normal
cytology hpvs 51 (n = 30), 66 (n = 25) 16 (n = 25), among women with
hsil asc-h (n = 14) hpvs 58 (n = 5) 16 (n = 5). determinants associated
with hpv dna detection occasional partner last 6
months smoking habit among gp women, minor among sw. hpv and
abnormal cytology prevalence high among women guatemala. introduction
of hpv vaccination program would prevent important fraction hpv-related
disease burden.

2009 uicc.

doi: 10.1002/ijc.24444 
pmid: 19415744  [indexed medline]

